d-609 has been researched along with Niemann-Pick-Diseases* in 3 studies
3 other study(ies) available for d-609 and Niemann-Pick-Diseases
Article | Year |
---|---|
Potential roles of membrane fluidity and ceramide in hyperthermia and alcohol stimulation of TRAIL apoptosis.
We recently reported that a mild heat shock induces a long lasting stimulation of TRAIL-induced apoptosis of leukemic T-lymphocytes and myeloid cell lines, but not normal T-lymphocytes, which correlates with an enhanced ability of TRAIL to recognize its receptors. As shown here, this phenomenon could be inhibited by the xanthogenate agent D609, a sphingomyelin/ceramide pathway inhibitor. A caspase-dependent and D609-sensitive two-fold increase in ceramide level was elicited by heat shock plus TRAIL combined treatment. One day after heat shock, a similar increase in ceramide was induced by TRAIL. Sphingolipids/ceramides are known to regulate membrane integrity, and heat shock increases membrane fluidity. In this regard, the heat shock plus TRAIL combined treatment resulted in a D609-sensitive membrane fluidization which was far more intense than that induced by heat shock only. We also report that membrane fluidizers, that mimic the effect of heat shock, such benzyl alcohol and ethanol, potently stimulated TRAIL-induced apoptosis. As heat shock, these alcohols increased, in a D609-sensitive manner, membrane fluidity in the presence of TRAIL, the recognition of TRAIL death receptors, and ceramide levels. These results suggest that stress agents that trigger ceramide production and an overall increase in membrane fluidity are stimulators of TRAIL apoptosis. Topics: Apoptosis; Benzyl Alcohol; Bridged-Ring Compounds; Caspases; Ceramides; Ethanol; HL-60 Cells; Hot Temperature; Humans; Indolizines; Jurkat Cells; Membrane Fluidity; Models, Biological; Niemann-Pick Diseases; Norbornanes; Phenethylamines; Thiocarbamates; Thiones; TNF-Related Apoptosis-Inducing Ligand; U937 Cells | 2007 |
Nitric oxide production stimulated by the basic fibroblast growth factor requires the synthesis of ceramide.
Nitric oxide (NO) is an intracellular and intercellular mediator involved in the modulation of many physiologic and pathologic processes including the regulation of neoangiogenesis. We analyzed the effects of basic fibroblast growth factor (bFGF) on NO production in CHO-K1 cells and the intracellular mechanisms involved. bFGF induces NO production through activation of the endothelial NO synthase (eNOS), causing a subsequent increase in cGMP levels. In most systems, eNOS activation is a Ca(2+)-calmodulin-dependent process. In CHO-K1 cells, NO production by bFGF is Ca(2+) and MAP kinase independent, because it was not reverted by pretreatment with intracellular Ca(2+) chelators or MEK inhibitors. Translocation of the eNOS from the plasma membrane, where it is bound to caveolin 1, to the cytosol is the crucial step in the synthesis of NO. We demonstrate that the cytosolic translocation of eNOS is caused by increased synthesis of ceramide dependent by the bFGF activation of sphingomyelinase. Indeed, in the presence of the sphingomyelinase inhibitors D609 or desipramine, bFGF-dependent NO production is abrogated. To support this evidence we evaluated ceramide concentration using HPLC-electrospray ionization-mass spectrometry in controls and in bFGF-treated cells: after bFGF stimulation, a substantial increase in ceramide levels was observed. These data were further confirmed by the lack of NO production in response to fibroblast growth factor in fibroblasts derived from Niemann Pick patients who genetically lack the enzyme sphingomyelinase. In conclusion, ceramide in CHO-K1 cells is responsible for a novel Ca(2+)/calmodulin-independent mechanism for eNOS activation after fibroblast growth factor stimulation. Topics: Animals; Bridged-Ring Compounds; Cells, Cultured; Ceramides; CHO Cells; Cricetinae; Cyclic GMP; Desipramine; Enzyme Activation; Fibroblast Growth Factor 2; Fibroblasts; Humans; Kinetics; Niemann-Pick Diseases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norbornanes; Phosphodiesterase Inhibitors; Reference Values; Thiocarbamates; Thiones | 2002 |
Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
The aim of the present study was to investigate the role of the entitled neutral, sphingomyelinase in the non-lysosomal pathway of sphingomyelin degradation by intact cells (Spence et al. (1983) J. Biol. Chem. 258, 8595-8600; Levade et al. (1991) J. Biol. Chem. 266, 13519-13529). The uptake and degradation of sphingomyelin by intact living cells was studied using cell lines exhibiting a wide range of activity levels of acid, lysosomal and neutral sphingomyelinases as determined in vitro on cell homogenates by their respective standard assays. For this purpose, neuroblastoma, skin fibroblasts, lymphoid and leukemic cell lines, some of them derived from patients with Niemann-Pick disease (deficient in the acid, lysosomal sphingomyelinase) were incubated with radioactive, [oleoyl-3H]sphingomyelin or fluorescent, pyrene-sulfonylaminoundecanoyl-sphingomyelin. Either compound was taken up by a pathway which was not receptor-mediated and hydrolyzed by all intact cells, including those derived from Niemann-Pick disease patients. Moreover, their degradation by the intact cells was not inhibited by treatment with chloroquine, indicating hydrolysis by a non-lysosomal sphingomyelinase. The intracellular sphingomyelin degradation rates showed no correlation with the activity of the 'classical' neutral sphingomyelinase as determined in vitro. In particular, fibroblasts derived from Niemann-Pick patients lacking the lysosomal sphingomyelinase, and having no detectable in vitro activity of the 'classical' neutral sphingomyelinase, were able to degrade the exogenously supplied sphingomyelins. Indeed, in vitro these cells were shown to exhibit neutral, magnesium- and dithiothreitol-dependent sphingomyelinase activities, that might contribute to the non-lysosomal pathway for sphingomyelin degradation to ceramide in intact cells. Topics: Bridged-Ring Compounds; Cell Line; Chloroquine; Dithiothreitol; Edetic Acid; Endocytosis; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Hydrolysis; Lysosomes; Magnesium; Niemann-Pick Diseases; Norbornanes; Phosphodiesterase Inhibitors; Sphingomyelin Phosphodiesterase; Sphingomyelins; Thiocarbamates; Thiones; Tumor Cells, Cultured; Zinc | 1995 |